EUVIMEDEUVIMED entdecken
Crossref

Impact of BRAF Gene Mutation in Nonmetastatic Colorectal Cancer on Disease Progression and Survival Outcomes

Caroline Lum iD, Harrison Boka iD, Mohammad Asghari-Jafarabadi iD, Shehara Mendis iD, Lauren Cohen iD, Helen E Abud iD, Rebekah M Engel iD, Paul J McMurrick

Journal of Gastroenterology and Hepatology · 2026

DOI: 10.1111/jgh.70215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2026. Verfasst von Caroline Lum und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Developmental Biology, Monash University, Clayton, Australia. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Colorectal Neoplasms, Mutation. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Let's Beat Bowel Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Colorectal cancer (CRC) is a major global health concern, with molecular and histopathological subtypes influencing disease progression. Mutations in the v‐Raf murine sarcoma viral oncogene homolog B (BRAF) gene, particularly the V600E variant, define a subset associated with aggressive features. The impact of BRAF mutations on early‐stage CRC prognosis and their interaction with mismatch repair (MMR) status remains less characterized.

Methods

We conducted a retrospective analysis of prospectively collected data from two tertiary institutions on Stage II–III CRC patients. BRAF/MMR subgroups were defined (BRAFmut/pMMR, BRAFmut/dMMR, BRAFwt/pMMR, and BRAFwt/dMMR). Associations with patient/tumor characteristics, adjuvant treatment, and long‐term outcomes were assessed. Univariate and multivariate analyses were used to evaluate disease recurrence and mortality.

Results

Of 157 eligible patients, univariate analyses indicated poorer outcomes for those with pMMR CRC. Multivariate analysis examining disease recurrence and death highlights that pMMR patients perform worse, but significantly, this analysis revealed that BRAFmut is a significant predictor of mortality in the nonmetastatic setting, irrespective of MMR status.

Conclusions

Nonmetastatic BRAFmut CRC carries a dismal prognosis, irrespective of MMR status. Routine testing for BRAF V600E mutation alongside MMR assessment is advocated to inform personalized management, potentially impacting surveillance, adjuvant therapy decisions, and eligibility for targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins B-rafColorectal NeoplasmsMutationHumansDisease ProgressionRetrospective StudiesDNA Mismatch RepairFemaleMalePrognosisNeoplasm StagingAgedMiddle AgedSurvival Rate

Stichwörter der Autor:innen

BRAF mutationearly colon cancerprognosissurvival

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, human

Autor:innen und Institutionen

  • Department of Anatomy and Developmental Biology, Monash University, Clayton, Australia.
  • Stem Cells and Development Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia.
  • Department of Oncology, Monash Health, Clayton, Australia.
  • Cabrini Research, Cabrini Health, Malvern, Australia.
  • School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Department of Psychiatry, School of Clinical Sciences, Monash University, Clayton, Australia.

ORCID-Profile: Caroline Lum, Harrison Boka, Mohammad Asghari-Jafarabadi, Shehara Mendis, Lauren Cohen, Helen E Abud, Rebekah M Engel

Förderung

  • Let's Beat Bowel Cancer

Zitieren

APA

Lum, C., Boka, H., Asghari-Jafarabadi, M., Mendis, S., Cohen, L., Abud, H. E., Engel, R. M., & McMurrick, P. J. (2026). Impact of BRAF Gene Mutation in Nonmetastatic Colorectal Cancer on Disease Progression and Survival Outcomes. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70215

Vancouver

Lum C, Boka H, Asghari-Jafarabadi M, Mendis S, Cohen L, Abud HE, et al. Impact of BRAF Gene Mutation in Nonmetastatic Colorectal Cancer on Disease Progression and Survival Outcomes. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70215

BibTeX
@article{Lum2026,
  author = {Lum, Caroline and Boka, Harrison and Asghari-Jafarabadi, Mohammad and Mendis, Shehara and Cohen, Lauren and Abud, Helen E and Engel, Rebekah M and McMurrick, Paul J},
  title = {Impact of BRAF Gene Mutation in Nonmetastatic Colorectal Cancer on Disease Progression and Survival Outcomes},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  doi = {10.1111/jgh.70215}
}
Kostenlos starten →